IRADIMED CORP Operating Income

Quick Answer

IRADIMED CORP reported Operating Income of $26.15 million for fiscal year 2025.

IRADIMED CORP Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 $26.15M +19.0%
2024 $21.96M +9.6%
2023 $20.04M +28.2%
2022 $15.63M +59.2%
2021 $9.82M +1398.5%
2020 -$756.1K -108.7%
2019 $8.65M +44.0%
2018 $6.00M +367.2%
2017 $1.29M -88.2%
2016 $10.92M -5.2%
2015 $11.51M +275.5%
2014 $3.07M +10.0%
2013 $2.79M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 $6.83M +18.0% +0.7%
June 30, 2025 $6.79M +20.6% +25.0%
March 31, 2025 $5.43M +14.4% -6.2%
September 30, 2024 $5.79M -2.0% +2.9%
June 30, 2024 $5.63M +13.4% +18.5%
March 31, 2024 $4.75M +18.5% -19.6%
September 30, 2023 $5.91M +42.9% +19.0%
June 30, 2023 $4.96M +19.1% +23.9%
  • IRADIMED CORP showed an increase of +19.0% in Operating Income compared to the prior fiscal year.
  • Over the 2013–2025 period, IRADIMED CORP’s operating income has grown by 838.1% (from $2.79 million to $26.15 million).
  • The most recent figure is from IRADIMED CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment